The Severity of COVID-19 and its Correlation with Inflammation Biomarkers

Authors

  • Beni Indra Department of Anesthesiology, Faculty of Medicine, Universitas Andalas, Padang, West Sumatera, Indonesia
  • Nur Indrawaty Lipoeto Department of Nutrition, Faculty of Medicine, Universitas Andalas, Padang, West Sumatera, Indonesia
  • Hardisman Hardisman Department of Public Health and Community Medicine, Faculty of Medicine, Universitas Andalas, Padang, West Sumatera, Indonesia
  • Andani Eka Putra Department of Microbiology, Faculty of Medicine, Universitas Andalas, Padang, West Sumatera, Indonesia
  • Djong Hon Tjong Department of Biology, Faculty of Mathematics and Natural Science, Universitas Andalas, Padang, West Sumatera, Indonesia
  • Sukri Rahman Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Andalas, Padang, West Sumatera, Indonesia
  • Elfira Yusri Department of Clinical Pathology, Faculty of Medicine, Universitas Andalas, Padang, West Sumatera, Indonesia
  • Muhammad Ridho Bilhaq Senior Clerkship, Faculty of Medicine, Universitas Andalas, Padang, West Sumatera, Indonesia
  • Yusan Pratama Senior Clerkship, Faculty of Medicine, Universitas Andalas, Padang, West Sumatera, Indonesia
  • Yudha Risman Senior Clerkship, Faculty of Medicine, Universitas Andalas, Padang, West Sumatera, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2022.9639

Keywords:

COVID-19, Neutrophil-to-lymphocyte ratio, Neutrophil-to-monocyte ratio, Lymphocyte-to-monocyte ratio, Biomarkers

Abstract

Introduction: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov2) or Covid-19 has been spread quickly and caused 5 million deaths until February 2022. Severe symptoms of the infection may lead to death that prompt appropriate clinical diagnosis and adequate treatment going to be necessary. Covid-19 shows a severe inflammatory response which causes an imbalance in the immune response. Therefore, circulating biomarkers that can represent inflammation and immune status are potential predictors for the prognosis of COVID-19 patients. This study aims to know the role of Neutrophil-Lymphocyte Ratio (NLR), Neutrophil Monocyte Ratio (NMR), and Lymphocyte-monocyte Ratio (LMR) as inflammatory biomarkers for the severity of Covid-19.

Methodology: This study is a single-center retrospective cohort study. The sample of this study was taken by consecutive sampling with complete clinical data from 893 Covid-19 patients from Andalas University Teaching Hospital from April 2020 to September 2021. This study uses SPSS Version 25.0 for data management and analysis.

Result: Most of the degrees of Covid-19 infection were mild degrees as many as 597 people with an NLR average value of 2.07 (0.27-34.50), and NMR average value of 7.86 (3-46), an LMR average value of 3.67 (0.25-25), an ANC value of 3.990 (945-45). 14,608).  Most of the degrees of infection in patients with negative PCR results were moderate degrees as many as 70 people with a mean NLR value of 9.0694 (0.51-47.50), a mean NMR value of 18.6199 (1.15-47.50), and a mean LMR was 3.0324 (0.29-19.50), the ANC value was 9769.73 (1.088-37,219). There was a relationship between the degree of Covid-19 infection and the NLR value (p=0.144), as well as the LMR (p=0.000), NMR(p=0.000), and ANC (p=0.000). There was no relationship between the degree of infection in the negative PCR patient group and the NLR value (p=0.000), as well as the LMR (p=0.700), NMR(p=0.120), and ANC (p=0.90).

Conclusion: The severity of Covid-19 symptoms could be predicted through inflammatory biomarkers such as NLR, LMR, and NMR.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

World Health Organizations. COVID-19-China. Geneva: World Health Organization; 2020. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON233 [Last accessed on 2022 Jan 22].

World Health Organizations. WHO Coronavirus (COVID-19) Dashboard. Geneva: World Health Organizations; 2022. Available from: https://www.covid19.who.int/table [Last accessed on 2022 Feb 25].

Djaharuddin I, Munawwarah S, Nurulita A, Ilyas M, Tabri NA, Lihawa N. Comorbidities and mortality in COVID-19 patients. Gac Sanit. 2021;35:530-2. https://doi.org/10.1016/j.gaceta.2021.10.085 PMid:34929892 DOI: https://doi.org/10.1016/j.gaceta.2021.10.085

World Health Organizations. Living Guidance for Clinical Management of COVID-19. Geneva: World Health Organizastions; 2021. p. 63. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1 [Last accessed on 2021 Nov 23].

Lee H, Kim I, Kang BH, Um SJ. Prognostic value of serial neutrophil-to-lymphocyte ratio measurements in hospitalized community-acquired pneumonia. PLoS One. 2021;16(4):0250067. https://doi.org/10.1371/journal.pone.0250067 PMid:33857241 DOI: https://doi.org/10.1371/journal.pone.0250067

Pan L, Du J, Li T, Liao H. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with takayasu’s arteritis: A case-control study. BMJ Open. 2017;7(4):014451. https://doi.org/10.1136/bmjopen-2016-014451 PMid:28473512 DOI: https://doi.org/10.1136/bmjopen-2016-014451

Keskin H, Kaya Y, Cadirci K, Kucur C, Ziypak E, Simsek E, et al. Elevated neutrophil-lymphocyte ratio in patients with euthyroid chronic autoimmune thyreotidis. Endocr Regul. 2016;50(3):148-53. https://doi.org/10.1515/enr-2016-0017 PMid:27560798 DOI: https://doi.org/10.1515/enr-2016-0017

Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020;80(6):656-65. https://doi.org/10.1016/j.jinf.2020.03.041 PMid:32283155 DOI: https://doi.org/10.1016/j.jinf.2020.03.041

Jordan RE, Adab P, Cheng KK. Covid-19: Risk factors for severe disease and death. BMJ. 2020;368:1198. https://doi.org/10.1136/bmj.m1198 PMid:32217618 DOI: https://doi.org/10.1136/bmj.m1198

Ministry of Health and Family Welfare. Clinical Management Protocol for COVID-19. Vol. 12. New Delhi: Ministry of Health and Family Welfare; 2016. p. 754-7.

Yang AP, Liu JP Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84:106504. https://doi.org/10.1016/j.intimp.2020.106504 PMid:32304994 DOI: https://doi.org/10.1016/j.intimp.2020.106504

Liu J, Li S, Liu J, Liang B, Wang X, Wang H, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. https://doi.org/10.1016/j.ebiom.2020.102763 PMid:32361250 DOI: https://doi.org/10.1016/j.ebiom.2020.102763

Wang Y, He Y, Tong J, Qin Y, Xie T, Li J, et al. Characterization of an asymptomatic cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected individuals outside of Wuhan, China. Clin Infect Dis. 2020;71(16):2132-8. https://doi.org/10.1093/cid/ciaa629 PMid:32442265 DOI: https://doi.org/10.1093/cid/ciaa629

Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Deng Y, et al. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int J Infect Dis. 2020;96:131-5. https://doi.org/10.1016/j.ijid.2020.04.086 PMid:32376308 DOI: https://doi.org/10.1016/j.ijid.2020.04.086

Zhang L, Huang B, Xia H, Fan H, Zhu M, Zhu L, et al. Retrospective analysis of clinical features in 134 coronavirus disease 2019 cases. Epidemiol Infect. 2020;148:199. https://doi.org/10.1017/s0950268820002010 PMid:32878654 DOI: https://doi.org/10.1017/S0950268820002010

Sadigh S, Massoth LR, Christensen BB, Stefely JA, Keefe J, Sohani AR. Peripheral blood morphologic findings in patients with COVID-19. Int J Lab Hematol. 2020;42(6):248-51. https://doi.org/10.1111/ijlh.13300 PMid:32730694 DOI: https://doi.org/10.1111/ijlh.13300

Erdogan A, Can FE, Gönüllü H. Evaluation of the prognostic role of NLR, LMR, PLR, and LCR ratio in COVID-19 patients. J Med Virol. 2021;93(9):5555-9. https://doi.org/10.1002/jmv.27097 PMid:34019701 DOI: https://doi.org/10.1002/jmv.27097

Sun S, Cai X, Wang H, He G, Lin Y, Lu B, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta. 2020;507:174-80. https://doi.org/10.1016/j.cca.2020.04.024 PMid:32339487 DOI: https://doi.org/10.1016/j.cca.2020.04.024

Anurag A, Jha PK, Kumar A. Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients. Diabetes Metab Syndr Clin Res Rev. 2020;14(6):2099-102. https://doi.org/10.1016/j.dsx.2020.10.029 PMid:33160224 DOI: https://doi.org/10.1016/j.dsx.2020.10.029

Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools- Lartigue J, Crawford JM, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020;217(6):20200652. https://doi.org/10.1084/jem.20200652 PMid:32302401 DOI: https://doi.org/10.1084/jem.20200652

Downloads

Published

2022-05-27

How to Cite

1.
Indra B, Lipoeto NI, Hardisman H, Putra AE, Tjong DH, Rahman S, Yusri E, Bilhaq MR, Pratama Y, Risman Y. The Severity of COVID-19 and its Correlation with Inflammation Biomarkers. Open Access Maced J Med Sci [Internet]. 2022 May 27 [cited 2024 Nov. 21];10(A):911-5. Available from: https://oamjms.eu/index.php/mjms/article/view/9639